Holen Sie sich die Stockscreener-App
155.03
0.65%
-1.02
Schlusskurs vom Vortag:
$156.05
Offen:
$156.8
24-Stunden-Volumen:
7.67M
Relative Volume:
0.88
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.08%
1M Leistung:
-8.32%
6M Leistung:
+25.10%
1J Leistung:
+61.73%
1-Tages-Spanne:
$153.85
$157.17
1-Wochen-Bereich:
$152.56
$162.68
52-Wochen-Spanne:
$95.86
$169.89
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
155.03 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
379.77 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
771.35 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
774.83 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
289.70 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
744.50 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
State Street SPDR S&P Biotech ETF (XBI) stock price, news, quote and history - Yahoo Finance Australia
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach - Benzinga
Economy Grew 63%, 30-Year Treasury Lost 45% Since 2020State Street SPDR S&P Biotech ETF (ARCA:XBI), iS - Benzinga
SPDR S&P Biotech ETF (XBI) stock price, news, quote and history - Yahoo Finance UK
ETFs Investing in Tyra Bioscience, Inc Stocks - TradingView
ETFs Investing in Replimune Group, Inc. Stocks - TradingView
Biotech ETF XBI likely peaked after 60% rally a... - Pluang
Biotech: The Party's Over, The Top Is In (NYSEARCA:XBI) - Seeking Alpha
Best Performing ETFs: Top Returns at a Glance - TradingKey
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
How to Buy State Street SPDR S&P Biotech ETF (Derivatives) (XBI) in Anguilla with Credit Card Online - Bitget
VHT vs. XBI: Is Diversified Healthcare Exposure or Biotech Stocks the Smarter Choice for Investors? - fool.com
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets - Benzinga
Is State Street SPDR S&P Transportation ETF (XTN) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Eastern Progress
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - Yahoo Finance
ETFs Investing in Stoke Therapeutics, Inc. Stocks - TradingView
ETFs Investing in PTC Therapeutics, Inc. Stocks - TradingView
XBIState Street SPDR S&P Biotech ETF Options - Finviz
Our Biotech ETF Pick Is on a Roll. There’s Plenty of Reasons to Stay Bullish. - Barron's
Technical Analysis of State Street SPDR S&P Biotech ETF (CRYPTOCOM:XBIUSD.P) - TradingView
ETFs Investing in First Tracks Biotherapeutics Inc Stocks - TradingView
ETFs Investing in Novavax, Inc. Stocks - TradingView
5 Best Biotech ETFs for 2026 and How to Invest - The Motley Fool
KATT ETF Price and Chart — CBOE:KATT - TradingView
State Street SPDR S&P Biotech ETF (XBI) Stock Price Quote Today & Current Price Chart - Capital.com
7 Best Biotech ETFs to Buy Now | Investing - US News Money
Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back - Benzinga
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Should You Invest in the VanEck Biotech ETF (BBH)? - Eastern Progress
Is State Street SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - Yahoo Finance
Biotech Is Popping. No One Seems to Care. - The Daily Upside
What's Going On With Novavax Stock? - Benzinga
The Next Biotech Boom May Be Cancer Vaccines. Watch These ETFsModerna (NASDAQ:MRNA) - Benzinga
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Eastern Progress
Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing - CryptoRank
Novavax Stock Climbs Monday: What's Going On? - Benzinga
XBI Forecast: $174.79 Tests Biotech ETF Breakout Strength - FXEmpire
Analysts See Drastic Change For This Particular Part Of Healthcare - Investor's Business Daily
Equal-weight S&P 500 is leading the 2026 market and its flagship trade just hit $100 billion - CNBC
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade) (NYSEARCA:XBI) - Seeking Alpha
Moderna just gained $44 billion in value in a few hours - Opening Bell Daily
XBI: Biotech's Breakthrough Moment Happened This Week (Upgrade) (NYSEARCA:XBI) - Seeking Alpha
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck - Seeking Alpha
Novavax Stock Moves Higher Wednesday: What's Driving the Action? - Benzinga
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):